Table 4.
Odds ratios for emergency presentation 30 days prior to cancer diagnosis with all adjustment covariates
| Covariate | Lung cancer | Prostate cancer | Breast cancer | Colorectal cancer |
|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | |
| SMHA service use (Ref: none) | ||||
| SHMA service use | 1.54 (1.35, 1.76) | 2.44 (1.89, 3.12) | 1.57 (1.21, 2.02) | 1.66 (1.45, 1.89) |
| Age (Ref: 55–64 years) | ||||
| 15–44 | 1.37 (1.08, 1.75) | 3.77 (1.64, 7.69) | 0.92 (0.73, 1.16) | 2.26 (1.99, 2.56) |
| 45–54 | 1.13 (1.01, 1.27) | 0.91 (0.66, 1.23) | 0.75 (0.61, 0.92) | 1.08 (0.97, 1.20) |
| 65–74 | 1.04 (0.96, 1.12) | 1.24 (1.07, 1.44) | 1.38 (1.13, 1.67) | 1.10 (1.02, 1.18) |
| 75+ | 1.43 (1.33, 1.55) | 3.76 (3.26, 4.34) | 2.59 (2.18, 3.09) | 1.69 (1.58, 1.82) |
| Gender (Ref: Female) | ||||
| Male | 1.07 (1.01, 1.12) | - | - | 0.88 (0.84, 0.92) |
| Ethnicity (Ref: Māori) | ||||
| Non-Māori | 0.81 (0.75, 0.87) | 0.91 (0.76, 1.10) | 0.77 (0.65, 0.92) | 0.73 (0.65, 0.81) |
| Deprivation (Ref: 1 = low) | ||||
| 2 | 1.11 (1.00, 1.23) | 1.26 (1.07, 1.48) | 1.18 (0.96, 1.46) | 1.15 (1.07, 1.25) |
| 3 | 1.20 (1.09, 1.33) | 1.22 (1.04, 1.43) | 1.14 (0.93, 1.41) | 1.17 (1.08, 1.26) |
| 4 | 1.19 (1.08, 1.31) | 1.24 (1.06, 1.45) | 1.26 (1.04, 1.53) | 1.22 (1.13, 1.32) |
| 5 (high) | 1.37 (1.24, 1.50) | 1.61 (1.38, 1.90) | 1.60 (1.31, 1.94) | 1.43 (1.32, 1.55) |
| Stage (Ref: Localised) | ||||
| Regional spread | 3.55 (3.00, 4.20) | 1.82 (1.34, 2.50) | 2.26 (1.89, 2.70) | 2.25 (2.10, 2.40) |
| Distant metastases | 13.40 (11.49, 15.70) | 46.44 (36.24, 60.36) | 70.11 (58.83, 83.83) | 5.54 (5.14, 5.97) |
| Unknown | 4.27 (3.66, 5.01) | 1.99 (1.57, 2.56) | 6.23 (5.20, 7.47) | 1.48 (1.37, 1.60) |
Odds ratios fully adjusted for all covariates. Fully adjusted models exclude those missing NZDep (< 0.5% for each cancer: Lung excluded n = 106 / 24,083, 0.4%; Prostate missing NZDep = 59 / 38,117 = 0.2%; Breast missing n = 81 / 35,846 = 0.2%; Colorectal missing n = 107 / 34,642 = 0.3%)